Dr. Alencar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1503 B North Road Street
Elizabeth City, NC 27909Phone+1 252-331-2044
Summary
- Dr. Cristina Alencar is an oncologist in Elizabeth City, NC and is affiliated with multiple hospitals in the area, including Chesapeake Regional Medical Center and Sentara Albemarle Medical Center. She received her medical degree from Federal University of Ceara Faculty of Medicine and has been in practice 17 years. She specializes in hematologic oncology and is experienced in squamous cell carcinoma of the larynx, anemia of chronic kidney disease, branchiogenic carcinoma, tubular carcinoma of the breast, and squamous cell carcinoma of the oropharynx.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2006 - 2009
University of Miami/Jackson Health SystemResidency, Internal Medicine, 2003 - 2006
Federal University of Ceara Faculty of MedicineClass of 2000
Certifications & Licensure
VA State Medical License 2012 - 2026
NC State Medical License 2012 - 2025
KY State Medical License 2009 - 2015- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Publications & Presentations
PubMed
- 41 citationsAberrant Epigenetic and Genetic Marks Are Seen in Myelodysplastic Leukocytes and Reveal Dock4 as a Candidate Pathogenic Gene on Chromosome 7qLi Zhou, Joanna Opalinska, Davendra Sohal, Yiting Yu, Yongkai Mo
The Journal of Biological Chemistry. 2011-07-15 - 106 citationsReduced SMAD7 Leads to Overactivation of TGF-β Signaling in MDS that Can Be Reversed by a Specific Inhibitor of TGF-β Receptor I KinaseLi Zhou, Christine McMahon, Tushar D. Bhagat, Cristina Alencar, Yiting Yu
Cancer Research. 2011-02-01 - 20 citationsAtypical presentations of Sweet's syndrome in patients with MDS/AML receiving combinations of hypomethylating agents with histone deacetylase inhibitors.Cristina Alencar, Matthew Abramowtiz, Samir Parekh, Ira Braunshweig, Mark Jacobson
American Journal of Hematology. 2009-10-01
Press Mentions
Doctors and Patients Offer Hope for Women with Metastatic Breast CancerOctober 12th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
